ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Amneal Pharmaceuticals LLC

Official 2024 U.S. DOL Form 5500 summary for Amneal Pharmaceuticals LLC (Amneal Pharmaceuticals LLC And Subsidiaries 401(k) Plan · EIN 90-0186021 · PN 001): $278.49M net assets, 2,479 active participants, and $12.30 per $10,000 (12.30 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAmneal Pharmaceuticals LLC
Filing IdentifierAmneal Pharmaceuticals LLC And Subsidiaries 401(k) Plan · EIN 90-0186021 · PN 001
Plan Category & State401(k) Defined Contribution (NY)
Asset-Size Peer Cohort$100M-$500M
Plan Net Assets (2024)$278.49M
Active Participants2,479
Direct Admin Fee Rate$12.30 per $10,000 (12.30 bps)
Cohort Peer Median$9.75 per $10,000 (9.75 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI